Cargando…
Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance
We analyzed the changes in absolute lymphocyte count and its changes over time in 139 patients treated with preoperative chemoradiotherapy for locally advanced rectal cancer. The baseline absolute lymphocyte count was defined as the median of absolute lymphocyte count levels measured during 30 days...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024269/ https://www.ncbi.nlm.nih.gov/pubmed/29909729 http://dx.doi.org/10.1177/1533033818780065 |
_version_ | 1783336025769115648 |
---|---|
author | Oh, Seung Yeop Heo, Jaesung Noh, O Kyu Chun, Mison Cho, Oyeon Oh, Young-Taek |
author_facet | Oh, Seung Yeop Heo, Jaesung Noh, O Kyu Chun, Mison Cho, Oyeon Oh, Young-Taek |
author_sort | Oh, Seung Yeop |
collection | PubMed |
description | We analyzed the changes in absolute lymphocyte count and its changes over time in 139 patients treated with preoperative chemoradiotherapy for locally advanced rectal cancer. The baseline absolute lymphocyte count was defined as the median of absolute lymphocyte count levels measured during 30 days before preoperative chemoradiotherapy. Absolute lymphocyte count at 1 month, 0.5 to 1 year, 1 to 2 years, and 2 to 3 years were determined by the median values of the absolute lymphocyte counts during the respective periods. Absolute lymphocyte count decreased after delivering preoperative chemoradiotherapy, reached minimum level at 1 month, and then gradually increased after the completion of chemoradiotherapy. Baseline absolute lymphocyte count had significant correlations with the absolute lymphocyte count of every period (range of coefficient, 0.41-0.64, P < .001). The overall survival of the group with high baseline absolute lymphocyte count was significantly higher than that of the group with low baseline absolute lymphocyte count (5-year overall survival: 82.4% vs 62.9%, P = .012). In multivariable analyses, the baseline absolute lymphocyte count remained as a significant prognostic factor for overall survival, favoring the group with a high baseline absolute lymphocyte count (hazard ratio = 0.405, P = .017). This study showed that the level of baseline absolute lymphocyte count was an independent prognostic factor, and it correlated with the absolute lymphocyte counts across varying periods of treatments and follow-up in patients treated with preoperative chemoradiotherapy for rectal adenocarcinoma. |
format | Online Article Text |
id | pubmed-6024269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-60242692018-07-05 Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance Oh, Seung Yeop Heo, Jaesung Noh, O Kyu Chun, Mison Cho, Oyeon Oh, Young-Taek Technol Cancer Res Treat Original Article We analyzed the changes in absolute lymphocyte count and its changes over time in 139 patients treated with preoperative chemoradiotherapy for locally advanced rectal cancer. The baseline absolute lymphocyte count was defined as the median of absolute lymphocyte count levels measured during 30 days before preoperative chemoradiotherapy. Absolute lymphocyte count at 1 month, 0.5 to 1 year, 1 to 2 years, and 2 to 3 years were determined by the median values of the absolute lymphocyte counts during the respective periods. Absolute lymphocyte count decreased after delivering preoperative chemoradiotherapy, reached minimum level at 1 month, and then gradually increased after the completion of chemoradiotherapy. Baseline absolute lymphocyte count had significant correlations with the absolute lymphocyte count of every period (range of coefficient, 0.41-0.64, P < .001). The overall survival of the group with high baseline absolute lymphocyte count was significantly higher than that of the group with low baseline absolute lymphocyte count (5-year overall survival: 82.4% vs 62.9%, P = .012). In multivariable analyses, the baseline absolute lymphocyte count remained as a significant prognostic factor for overall survival, favoring the group with a high baseline absolute lymphocyte count (hazard ratio = 0.405, P = .017). This study showed that the level of baseline absolute lymphocyte count was an independent prognostic factor, and it correlated with the absolute lymphocyte counts across varying periods of treatments and follow-up in patients treated with preoperative chemoradiotherapy for rectal adenocarcinoma. SAGE Publications 2018-06-18 /pmc/articles/PMC6024269/ /pubmed/29909729 http://dx.doi.org/10.1177/1533033818780065 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Oh, Seung Yeop Heo, Jaesung Noh, O Kyu Chun, Mison Cho, Oyeon Oh, Young-Taek Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance |
title | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance |
title_full | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance |
title_fullStr | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance |
title_full_unstemmed | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance |
title_short | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance |
title_sort | absolute lymphocyte count in preoperative chemoradiotherapy for rectal cancer: changes over time and prognostic significance |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024269/ https://www.ncbi.nlm.nih.gov/pubmed/29909729 http://dx.doi.org/10.1177/1533033818780065 |
work_keys_str_mv | AT ohseungyeop absolutelymphocytecountinpreoperativechemoradiotherapyforrectalcancerchangesovertimeandprognosticsignificance AT heojaesung absolutelymphocytecountinpreoperativechemoradiotherapyforrectalcancerchangesovertimeandprognosticsignificance AT nohokyu absolutelymphocytecountinpreoperativechemoradiotherapyforrectalcancerchangesovertimeandprognosticsignificance AT chunmison absolutelymphocytecountinpreoperativechemoradiotherapyforrectalcancerchangesovertimeandprognosticsignificance AT chooyeon absolutelymphocytecountinpreoperativechemoradiotherapyforrectalcancerchangesovertimeandprognosticsignificance AT ohyoungtaek absolutelymphocytecountinpreoperativechemoradiotherapyforrectalcancerchangesovertimeandprognosticsignificance |